Table 5. Comparison of HbA1C values throughout the study.
HbA1C Range | Baseline Data | Data at 8 Months | Data at 14 Months | |||
---|---|---|---|---|---|---|
Number of Participants | Baseline HbA1C Values | Number of Participants | HbA1C Values at 8 Months | Number of Participants | HbA1C Values at 14 Months | |
<5 | 0 | 0 | 0 | 0 | 5 | 4.16±0.06 |
5.1–7 | 27 | 6.4±0.08 | 37 | 6.2±0.09 | 37 | 6.2±0.09 |
7.1–9 | 55 | 8.0±0.08 | 38 | 7.7±0.08 | 42 | 8.1±0.08 |
9.1–11 | 26 | 9.9±0.10 | 29 | 9.8±0.10 | 21 | 9.9±0.11 |
11.1–13 | 10 | 12.2±0.13 | 12 | 12.1±0.16 | 10 | 11.8±0.17 |
13.1–15 | 2 | 13.9±0.10 | 4 | 14.3±0.46 | 5 | 13.8±0.20 |
Comparison of HbA1C investigations across various time points during the study were mentioned. Range of HbA1C values, number of participants at baseline, 8 months and 14 months along with average HbA1C values and standard error were computed. Comparisons were made and statistical significance was determined using repeated measures ANOVA. The data was compared between baseline-8 months, baseline-14 months and 8 months-14 months found highly significant with P<0.0001.